Upexi Inc (UPXI) — Titan Protect Analysis

UPXI

Upexi Inc

Communication Services · ·

$0.95

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$73M

Total market value of the company

Trailing P/E

1.96

Very cheap relative to earnings

Forward P/E

-6.30

Based on estimated future earnings — lower means cheaper

Rev Growth

+44.2%

Year-over-year revenue change

Profit Margin

N/A

How much profit the company keeps from each dollar of revenue

ROE

N/A

Return on equity — how efficiently it uses shareholder money

Analyst Target

$5.00

+428% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 2 analysts covering this stock

About Upexi Inc

Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also

https://www.upexi.com

Country: United States Employees: 59 Industry: Internet Content & Information

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKDOWN

Price trending down — defensive positioning

Sharpe Ratio

0.414

Positive but modest risk-adjusted returns

Kelly Fraction

0.0370

Modest edge detected — smaller position warranted

Calmar Ratio

-0.709

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-68.3%

Historical annualised return based on price data

Max Drawdown

-96.4%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

N/A

52W High

$13.57

93% below the year high

52W Low

$0.54

75% above the year low

Avg Volume

4,552,406

Average daily shares traded — higher means easier to buy and sell

Short Ratio

4.6

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$0.53

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

N/A

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

87.0%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-2,343.3%

Profit from core operations before interest and tax

Free Cash Flow

$-229,092,160

Negative — the business is spending more than it generates

Revenue (TTM)

$26M

Total revenue over the last 12 months

Net Income

$-228,446,304

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$8.00

Target Median

$5.00

Target Low

$2.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go